Toward a Rational Solvent Selection for Conformational Polymorph Screening

Chemical Engineering in the Pharmaceutical Industry: R&D to Manufacturing

Volumn , Issue , 2010, Pages 491-504

  Abramov, Yuriy A ^a   Zell, Mark ^a   Krzyzaniak, Joseph F ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Crystallographic conformations of ritanovir forms I and II; Test of accuracy of conformational population predictions; Toward a rational solvent selection for conformational polymorph screening

Indexed keywords

EID: 84875170095     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470882221.ch26     Document Type: Chapter

References (45)

1. Bernstein J. Polymorphism in Molecular Crystals, Clarendon, Oxford, 2002.
2. Nangia A. Conformational polymorphism in organic crystals. Acc. Chem. Res. 2008;41:595-604.
3. Yu L, Reutzel-Edens SM, Mitchell CA. Crystallization and polymorphism of conformationally flexible molecules: problems, patterns, and strategies. Org. Proc. Res. Dev. 2000;4: 396-402.
4. Weissbuch I, Kuzmenko I, Vaida M, Zait S, Leiserowitz L, Lahav M. Twinned crystals of enantiomorphous morphology of racemic alanine induced by optically resolved a-amino acids: a stereochemical probe for the early stages of crystal nucleation. Chem. Mater. 1994;6:1258-1268.
5. Weissbuch I, Popoviz-Biro R, Leiswerowitz L, Lahav M. Lock-and-key processes at crystalline interfaces: relevance to the spontaneous generation of chirality. In: Behr J-P, editor. The Lock-and-Key Principle: The State of the Art-100 Years On, John Wiley & Sons, New York, 1994, pp. 173-246.
6. Lee AY, Lee IS, Dette SS, Boerner J, Myerson AS. Crystallization on confined engineered surfaces: a method to control crystal size and generate different polymorphs. J. Am. Chem. Soc. 2005;127:14982-14983.
7. LeeAY, Lee IS, Myerson AS. Factors affecting the polymorphic outcome of glycine crystals constrained on patterned substrates. Chem. Eng. Tech. 2006;29:281-285.
8. Weissbuch I, Addadi L, Leiswerowitz L. Molecular recognition at crystal interfaces. Science 1991;253:637-645.
9. Datta S, Grant DJW. Effect of supersaturation on the crystallization of phenylbutazone polymorphs. Cryst. Res. Technol. 2005;40:233-242.
10. Davey RJ, Blagden N, Righini S, Alison H, Ferrari ES. Nucleation control in solution mediated polymorphic phase transformations: the case of 2,6-dihydroxybenzoic acid. J. Phys. Chem. B 2002;106:1954-1959.
11. Davey RJ, Blagden N, Potts GD, Docherty R. Polymorphism in molecular crystals: Stabilization of a metastable form by conformational mimicry. J. Am. Chem. Soc. 1997;119: 1767-1772.
12. Mullin JW. Crystallization, Linacre House, Jordan Hill, Oxford, 1992.
13. Threlfall T. Structural and thermodynamic explanations of Ostwald's Rule. Org. Proc. Res. Dev. 2003;7:1017-1027.
14. Hursthouse MB, Huth S, Threlfall TL. Why do organic compounds crystallise well or badly or ever so slowly? Why is crystallization nevertheless such a good purification technique? Org. Proc. Res. Dev. 2009;13:1231-1240.
15. Blagden N, Davey RJ. Polymorph selection: challenges for the future? Cryst. Growth Des. 2003;3:873-885.
16. Cross WI, Blagden N, Davey, RJ, Pritchard, RG, Neumann, MA, Roberts, RJ, Rowe RC. A whole output strategy for polymorph screening: combining crystal structure prediction, graph set analysis, and targeted crystallization experiments in the case of diflunisal. Cryst. Growth Des. 2003;3:151-158.
17. Price SL. From crystal structure prediction to polymorph prediction: interpreting the crystal energy landscape. Phys. Chem. Chem. Phys. 2008;10:1996-2009.
18. Price SL. The computational prediction of pharmaceutical crystal structures and polymorphism. Adv. Drug Del. Rev. 2004;56:301-319.
19. Ouvrard C, Price SL. Toward crystal structure prediction for conformationally flexible molecules: the headaches illustrated by aspirin. Cryst. Growth Des. 2004;4:1119-1127.
20. Day GM, Motherwell WDS, JonesW. A strategy for predicting the crystal structures of flexible molecules: the polymorphism of phenobarbital. Phys. Chem. Chem. Phys. 2008;9: 1693-1704.
21. Cooper TG, Hejczyk KE, Jones W, Day GM. Molecular polarization effects on the relative energies of the real and putative crystal structures of valine. J. Chem. The. Comput. 2008;4:1795-1805.
22. Weng ZF, Motherwell WDS, Allen FH, Cole JM. Conformational variability of molecules in different crystal environments: a database study. Acta Cryst. 2008; B64:348-362.
23. MOE 2008.10, Chemical Computing Group, Inc., 1010 Sherbrooke Street West, Suite 910, Montréal, Québec, Canada. http://www.chemcomp.com
24. Delley B. An all-electron numerical method for solving the local density functional for polyatomic molecules. J. Chem. Phys. 1990;92:508-517.
25. Delley B. From molecules to solids with the DMol3 approach. J. Chem. Phys. 2000;113:7756-7764.
26. Accelrys Software. Material Studio 4.4 DMol3; Accelrys Software, Inc., San Diego, CA, 2008.
27. Perdew JP, Burke K, Ernzerhof M. Generalized gradient approximation made simple. Phys. Rev. Lett. 1996;77: 3865-3868.
28. Andzelm J,Kölmel C, Klamt A. Incorporation of solvent effects into density functional calculations of molecular energies and geometries. J. Chem. Phys. 1995;103:9312-9320.
29. Zhao Y, Truhlar DG. Benchmark databases of nonbonded interactions and their use to test density functional theory. J. Chem. Theory Comput. 2005;1:415-432.
30. Klampt A. COSMO-RS: From Quantum Chemistry to Fluid- Phase Thermodynamics and Drug Design, Elsevier, Amsterdam, 2005.
31. COSMOtherm, Version C2.1_0109, COSMOLogic GmbH, Leverkusen, Germany.
32. Lein M, Dobson JF, Gross EKU. Towards the description of van der Waals interactions within density functional theory. J. Comput. Chem. 1999;20:12-22.
33. Weigend F,Häser M, Patzelt H, Ahlrichs R. RI-MP2: optimized auxiliary basis sets and demonstration of efficiency. Chem. Phys. Lett. 1998;294:143-152.
34. TURBOMOLE, V6.0 2009, a development of University of Karlsruhe and Forschungszentrum Karlsruhe GmbH, 1989-2007, TURBOMOLE GmbH, since 2007.
35. Keeler J, Neuhaus D, Titman JJ. A convenient technique for the measurement and assignment of long-range carbon-13 proton coupling constants. Chem. Phys. Lett. 1988;146:545-548.
36. Yamasaki R, Tanatani A, Azumaya I, Masu H, Yamaguchi K, Kagechika H. Solvent-dependent conformational switching of N-phenylhydroxamic acid and its application in crystal engineering. Cryst. Growth Des. 2006;9:2007-2010.
37. Forbes CC, Beatty AM, Smith BD. Using pentafluorophenyl as a Lewis acid to stabilize a cis secondary amide conformation. Org. Lett. 2001;3:3595-3598.
38. Gu C, Young JrV, Grant DJW. Polymorphs screening: influence of solvents on the rate of solvent-mediated polymorphic transformation. J. Pharm. Sci. 2001;90:1878-1890.
39. MillerJM,CollmanBM,GreeneLR,GrantDJW,BlackburnAC. Identifying the stable polymorph early in the drug discovery-- development process. Pharm. Dev. Technol. 2005;10:291-297.
40. Ostwald W. Studien Uber Die Bildung und Umwandlung Fester Korper. Z. Physik. Chem. 1897;22:289-302.
41. Maruyama S, Ooshima H, Kato J. Crystal structures and solvent-mediated transformation of taltireline polymorphs. Chem. Eng. J. 1999;75:193-200.
42. Maruyama S, Ooshima H. Mechanism of the solvent-mediated transformation of taltirelin polymorphs promoted by methanol. Chem. Eng. J. 2001;81:1-7.
43. Allen FH, Bellard S, Brice MD, Cartwright BA, Doubleday A, Higgs H, Hummelink TWA, Hummelink-Peters BG, Kennard O, Motherwell WDS, Rodgers JR,Watson DG. The Cambridge Structural Database: a quarter of a million crystal structures and rising. Acta Cryst. 1979;B35:2331-2339.
44. Lu J, Wang X-J, Yand X, Ching C-B. Characterization and selective crystallization of famotidine polymorphs. J. Pharm. Sci. 2007;96:2457-2468.
45. Chemburkar SR, Bauer J, Deming K, Spiwek H, Patel K, Morris J, Henry R, Spanton S, Dziki W, Porter W, Quick J, Bauer P, Donaubauer J, Narayanan BA, Soldani M, Riley D, McFarland K. Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development. Org. Proc. Res. Dev. 2000;4:413-417.